Klaus H�ffken
Impact in
-
- Neutropenia and Cancer Infections
- Bone health and treatments
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Neutropenia and Cancer Infections 3
-
- Acute Myeloid Leukemia Research 2
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- Joachim H. Clement (5 shared papers)Holger W. Auner (1 shared paper)Xaver Schiel (1 shared paper)Wolfgang Kern (1 shared paper)Rolf Mahlberg (1 shared paper)M. R. Nowrousian (1 shared paper)Hartmut Link (1 shared paper)Markus Ruhnke (1 shared paper)
- Journals
- Journal of Cancer Research and Clinical Oncology (10 papers)Annals of Hematology (3 papers)Cancer Immunology Immunotherapy (2 papers)International Journal of Cancer (2 papers)Supportive Care in Cancer (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Klaus H�ffken
21 papers receiving 461 citations
Peers
Comparison fields: 5 of 62
- Oncology 222
- Clinical Biochemistry 44
- Geriatrics and Gerontology 12
- Hematology 40
- Emergency Medicine 23
Countries citing papers authored by Klaus H�ffken
This map shows the geographic impact of Klaus H�ffken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus H�ffken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus H�ffken more than expected).
Fields of papers citing papers by Klaus H�ffken
This network shows the impact of papers produced by Klaus H�ffken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus H�ffken. The network helps show where Klaus H�ffken may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus H�ffken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 183 | |
| 2 | 2000 | 64 | |
| 3 | 1999 | 58 | |
| 4 | 1989 | 40 | |
| 5 | 1999 | 35 | |
| 6 | 1993 | 22 | |
| 7 | 2004 | 15 | |
| 8 | 2003 | 14 | |
| 9 | 1971 | 13 | |
| 10 | 1997 | 10 | |
| 11 | 2005 | 8 | |
| 12 | 1996 | 7 | |
| 13 | 2003 | 4 | |
| 14 | 1985 | 3 | |
| 15 | 1974 | 2 | |
| 16 | 1976 | 2 | |
| 17 | 1976 | 2 | |
| 18 | 1979 | 2 | |
| 19 | 2003 | 2 | |
| 20 | 1976 | 1 |
About Klaus H�ffken
Klaus H�ffken is a scholar working on Oncology, Hematology, Cancer Research, Reproductive Medicine and Rheumatology, having authored 21 papers that have together received 488 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (3 papers), Cancer Treatment and Pharmacology (3 papers), Neutropenia and Cancer Infections (3 papers), Testicular diseases and treatments (3 papers), Ovarian cancer diagnosis and treatment (2 papers), Breast Cancer Treatment Studies (2 papers), Acute Myeloid Leukemia Research (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Oncology (222 citations), Clinical Biochemistry (44 citations), Geriatrics and Gerontology (12 citations), Hematology (40 citations) and Emergency Medicine (23 citations). Klaus H�ffken has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Joachim H. Clement, Holger W. Auner, Xaver Schiel, Wolfgang Kern, Rolf Mahlberg, M. R. Nowrousian, Hartmut Link, Markus Ruhnke, Orhan Sezer and Martin Wilhelm. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Annals of Hematology, Cancer Immunology Immunotherapy, International Journal of Cancer and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.